Gatot Soebroto Army Hospital is a hospital in Jakarta, Indonesia. The name of the hospital is derived from Gatot Soebroto, a National Hero of Indonesia. Established in 1819, the hospital is the main hospital for the Indonesian Army. The hospital also provides limited services for civilians.

During the past decade, Gatot Soebroto Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gatot Soebroto Hospital" are "Ischemic Stroke" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Gatot Soebroto Hospital" in a lesser frequency.

Most popular intervention types in "Gatot Soebroto Hospital" are "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome" (1 trials), "Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome" (1 trials), "Conditioned Medium" (1 trials), "Neurologic and Neutrophic Drugs" (1 trials) and "Non Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gatot Soebroto Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Gatot Soebroto Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gatot Soebroto Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gatot Soebroto Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".